Sarepta Therapeutics OverviewSarepta Therapeutics Net Income
Profitability analysis for SRPT.
Quarterly Net Income
$330.96M
↑ 173.96% YoY
As of Mar 2026
Annual Net Income (TTM)
-$64.32M
↑ 74.1% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...